Navigation Links
Misonix Announces Interim Distribution Agreement for Italy
Date:11/3/2008

he mobile fee for service business segment makes Lithomobile a particularly appealing distribution partner, whose strengths blend well with Misonix's business strategy for HIFU."

About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at http://www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, r
'/>"/>

SOURCE Misonix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... , ... Argonne, Ill. (Vocus) ... Energy’s (DOE) Argonne National Laboratory and Northwestern University, Evanston, ... in a solution, providing insights for design of bio-inspired dynamically ... million times more massive than the bacteria,” said physicist and ...
(Date:12/16/2009)... Dec. 16 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, according to ... and Abbott,s briakinumab (both interleukin inhibitors) will capture ... in the drug market for moderate to severe ... greater uptake, capturing nearly three times as much ...
(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...
(Date:12/16/2009)... HSP A has been found to be effectinve in improving yelds ... ... -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand ... manufactured by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy ... HSP-A has been found to be especially effective in improving ...
Breaking Biology Technology:Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
... security guards came to the DHS Science and Technology Directorates ... list was an emergency escape hood worthy of James Bond: ... pound, folding to the dimensions of a DVD case, and ... must be maintenance-free, filter nerve, blood, and blister agents, remove ...
... SUNNYVALE, Calif., April 21 /PRNewswire-FirstCall/-- Pharmacyclics,Inc. (Nasdaq: ... Nasdaq staff,deficiency letter on April 17, 2008 indicating ... price for Pharmacyclics, common stock has closed,below the ... share for continued,inclusion on The Nasdaq Global Market ...
... $18.9 Million Net Revenues, $0.03 Net Loss Per Share, ... Inc. (Nasdaq: VNUS ), a leading provider of ... today announced its,financial results for the first quarter ended ... quarter of 2008 increased 21% to $18.9,million compared with ...
Other Biology Technology:Boys in the Hood 2VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 2VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 3VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 4VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 5VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 6VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% growth in Net Revenues and 51% Growth in Unit Sales 7
(Date:12/16/2009)... seasonal exposure to pesticides in rivers and basins ... salmon populations. In addition to the widespread deterioration ... to commonly used pesticides may further inhibit the ... "Major efforts are currently underway to restore Pacific ... populations," says David Baldwin of the National Oceanic ...
(Date:12/16/2009)... Dec. 1 GestureTek Inc. today ... 3.0 - a turnkey, portable, plug and ... exhibits, entertainment and touring promotions. GestureTek is ... patents in camera-enabled gesture recognition technology for ... Guaranteed for quality, the CUBE has TUV, ...
(Date:12/16/2009)... 2009 National Instruments (Nasdaq: ... and control, and DENSO Robotics, a leader ... technology, today announced their collaboration to integrate ... robotic arms. The collaboration increases productivity and ... manufacturing applications. In today,s trend toward high-mix, ...
Breaking Biology News(10 mins):Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Baylor University Medical Center at Dallas Recognized for Exemplary Surgical Patient Care 58634 1Baylor University Medical Center at Dallas Recognized for Exemplary Surgical Patient Care 58634 2Baylor University Medical Center at Dallas Recognized for Exemplary Surgical Patient Care 58634 3iTech Medical Provides Update on MPR Clinical Development Plan 58632 1iTech Medical Provides Update on MPR Clinical Development Plan 58632 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 3iTech Medical Provides Update on MPR Clinical Development Plan 58632 4Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 58630 1Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 58630 2Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 58630 3
... during a long-distance race may do serious harm rather ... too much, according to a cardiologist at UT Southwestern ... drink too much water during a race could put ... by a loss in the body's sodium content that ...
... of scientists led by biophysicist Stuart Lindsay from ... created the first reproducible single molecule negative differential ... groundbreaking experimental technique that provides a “roadmap?for designing ... were presented Feb. 18 by Lindsay at the ...
... today the launch of the new GeneChip(R) Globin-Reduction ... PreAnalytiX -- a joint venture between QIAGEN N.V. ... (Becton, Dickinson and Company). The new kits optimize ... with Affymetrix GeneChip technology and improve gene expression ...
Other Biology News:Bush, Cheney and Rumsfeld are now species of slime-mold beetles -- but strictly in homage 2Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics 2Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics 3Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX 2Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX 3